Improvement in liver disease parameters following treatment with daclatasvir + sofosbuvir and ribavirin in patients with chronic HCV infection and advanced cirrhosis [Abstract 706]

Fontana RJ, Poordad F, Schiff ER, Vierling JM, Landis CS, Bhore R, et al. Improvement in liver disease parameters following treatment with daclatasvir + sofosbuvir and ribavirin in patients with chronic HCV infection and advanced cirrhosis [Abstract 706]. In 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), November 13-17, 2015. San Francisco; 2015.

Publication Type:

Conference Paper

Authors:

Robert J Fontana; Fred Poordad; E R Schiff; John M. Vierling; Charles S. Landis; Rafia Bhore; Philip Yin; Stephanie Noviello; Eugene S. Swenson

Source:

66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), November 13-17, 2015, Number 706, San Francisco (2015)

Abstract:

706

Export Citation:
RIS Format
Top